tert-Butyl (S)-5-(hydroxymethyl)-5,6,9,10-tetrahydro-4H-isoxazolo[3,4-c]pyrido[4',3':3,4]pyrazolo[1,5-a]azepine-11(12H)-carboxylate

Catalog No. :
ACXYKX286
CAS No. :
2564787-42-2
Molecular Formula :
C18H24N4O4
Molecular Weight :
360.41

IUPAC Name:tert-butyl (S)-5-(hydroxymethyl)-5,6,9,10-tetrahydro-4H-isoxazolo[3,4-c]pyrido[4',3':3,4]pyrazolo[1,5-a]azepine-11(12H)-carboxylate

tert-Butyl (S)-5-(hydroxymethyl)-5,6,9,10-tetrahydro-4H-isoxazolo[3,4-c]pyrido[4',3':3,4]pyrazolo[1,5-a]azepine-11(12H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (S)-5-(hydroxymethyl)-5,6,9,10-tetrahydro-4H-isoxazolo[3,4-c]pyrido[4',3':3,4]pyrazolo[1,5-a]azepine-11(12H)-carboxylate
IUPAC Nametert-butyl (S)-5-(hydroxymethyl)-5,6,9,10-tetrahydro-4H-isoxazolo[3,4-c]pyrido[4',3':3,4]pyrazolo[1,5-a]azepine-11(12H)-carboxylate
Molecular FormulaC18H24N4O4
Molecular Weight360.41
SMILESO=C(N1CCC2=NN3C(C4=NOC=C4C[C@H](CO)C3)=C2C1)OC(C)(C)C
InChI KeyIRUPQMNEMURPDV-NSHDSACASA-N
SynonymTert-butyl (S)-5-(hydroxymethyl)-5,6,9,10-tetrahydro-4H-isoxazolo[3,4-c]pyrido[4,3:3,4]pyrazolo[1,5-a]azepine-11(12H)-carboxylate;4H-Isoxazolo[3,4-c]pyrido[4′,3′:3,4]pyrazolo[1,5-a]azepine-11(12H)-carboxylic acid, 5,6,9,10-tetrahydro-5-(hydroxymethyl)-, 1,1-dimethylethyl ester, (5S)-
CAS No.2564787-42-2

Synthetic Route by SureRoute

1. ACXYKX286 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXYKX286 route product structure diagram
    ACXYKX2862564787-42-2
Inquiry

2. ACXYKX286 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXYKX286 route product structure diagram
    ACXYKX2862564787-42-2
Inquiry

Comments (0)